Commonwealth Bank of Australia’s Harvard Bioscience HBIO Stock Holding History

Commonwealth Bank of Australia’s Portfolio HBIO Stock Details HBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-2,357	Closed	-$112K	–	897
2014 Q1	$112K	Hold	2,357	–	–	﹤0.01%	1227
2013 Q4	$111K	Sell	2,357 -751	-24%	-$32.8K	﹤0.01%	1202
2013 Q3	$124K	Hold	3,108	–	–	﹤0.01%	1181
2013 Q2	$111K	Buy	+3,108	New	+$119K	﹤0.01%	1172

Other funds holding HBIO

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Commonwealth Bank of Australia's HBIO Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Harvard Bioscience (HBIO) in Q2 2014, closing a stake of 2,357 shares — an estimated $112K sold.

Commonwealth Bank of Australia first reported a position in HBIO in Q2 2013 and held it in 4 quarters. The position peaked at $124K in Q3 2013. 74 funds tracked by Wall St. Rank hold HBIO as of Q2 2014.

Commonwealth Bank of Australia reported no remaining Harvard Bioscience position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 2,357 Harvard Bioscience shares in Q2 2014, an estimated $112K.
Commonwealth Bank of Australia first reported a position in Harvard Bioscience in Q2 2013 and held it in 4 quarters.
Commonwealth Bank of Australia's Harvard Bioscience position peaked at $124K in Q3 2013.
74 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.